The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
This is meant as genuine. Is Global the author of that article? Maybe they are someone who can influence share price if so! We could maybe ask and get some positive stuff written instead. Energyshares, would you be willing to cooperate and talk with Global to change the narrative?
The first video on this thread was from May so it’s not exactly new. Is there another test out there that works in a pregnancy style though? If not it’s got to be Avacta and previously in an investor video Alistair Smith did answer a question to infer that the US government was aware of them
The quote wasn’t aimed at anyone in particular, it’s just one that I remembered from the large amount of threads started between 7-8am. I can’t argue with anything you have just said there PL, my aim was to temper the expectations of people that think every RNS is going to send the SP up like a rocket. Markets like concrete evidence and even better with numbers attached. PI’s have very little say on a share price when when there are hundreds of millions of shares valued where Avacta’s are at. It’s the institutional investors that will make the difference and with the money they are playing with, they prefer waiting for a guaranteed 50% rise than a ‘potential’ 200%.
For PI’s prepared to wait, this is great news but unfortunately it’s just a little bit longer until we get to reap the rewards of patience.
Went even worse than I thought! I presumed it would climb but stay in the recent bracket of 125-150ish. It’s dropped almost immediately with barely any spike after the ‘Now THIS is an RNS’ brigade were predicting huge things.
Validation, then followed by sales data and this will fly no doubt. Just remember, the majority of people that will make a share price change significantly, when the company has 250million shares, want concrete evidence and data. This is great news and the markets will monitor but not move on it just yet.
Just to be clear, the news is great. Massive production capacity and huge potential. If I’m wrong and this flies then happy days. I’m just tempering my own expectation and not expecting to break the 150 resistance with no validation and completed trials
Great news but I doubt it will do much to the share price today. No sales data, and no date for production. Just more time needed for data transfer.
Don’t get me wrong, long term this is great news with the ramping up of capacity to a huge number and now worldwide, but I don’t think the SP will make moves today.
Ok, but Sona have a viable covid product. Avacta don’t... yet. I believe it’s coming but I’m also realistic as to why the share price isn’t through the roof on conjecture and unproven information. Potential is massive - reality is nothing has happened... yet.
Because there are no covid products ! For this share price to rise there needs to be some figures of sales data, cash generation, production capacity and further partnerships. Updates on the development of products might show things are heading in the right direction but until the numbers are released don’t expect the share to rise
Got to be fair with the SP today, after reading the news this morning I thought it would be a bloodbath without an RNS of our own but it’s held up ok. A drop was inevitable but to still be where we are is encouraging and shows there’s some committed investors willing to sit on their shares. I took a risk and offloaded to big back cheaper. Won’t be doing that again as even though I benefitted a bit, the stress was far too much in case I locked myself out
You can buy and sell extremely easily and in large volume, no one is trying to accumulate or get rid of significant amounts of shares or holding anything back. There’s a lot of buys because the price is now cheap (relatively), there have also been a lot of sells
Nothing to do with MMs. The news is flooded with a quick test that isn’t Avacta. I’m staying fully invested as the potential here is so much better but this is a real drop, don’t be fooled into thinking otherwise. I would view it as a good chance for new investors to get on board and existing ones to top up If they desire
Share price might well fall back, I got a few in the portfolio with ODX just in case they come good. Probably a bit of FOMO. Need some good sales info in the next RNS as anything else wont do much. Good PR and interviews in the press are better for the share price than non monetary updates. However can’t wait for AVCT to take off, much better and more relevant than antibody testing.